大豆肽联合二陈汤加味对中晚期胃肠道恶性肿瘤患者化疗期间营养状态及生活质量的影响
|
陈德荣，刘艳，王蒙
|
临沂金锣医院，山东临沂，230036
|
摘要：目的 探究大豆肽联合二陈汤加味对中晚期胃肠道恶性肿瘤患者化疗期间营养状态及生活
质量的影响。方法 随机选择本院 2024 年 1 月～2025 年 5 月间收治的中晚期胃肠道恶性肿瘤患者
100 例进行研究，以随机数字表法分 2 组。对照组 50 例，予以常规营养支持。观察组 50 例，联用
大豆肽+二陈汤加味。比较两组疗效。结果 观察组化疗相关不良反应发生率低于对照组（P＜0.05）。观察组干预后营养状态以及生活质量得分均优于对照组（P＜0.05）。结论 中晚期胃肠道恶性肿
瘤患者化疗期间，大豆肽联合二陈汤加味可减少化疗相关不良反应，还可改善患者营养状态、生
活质量，值得推广。
关健词：中晚期胃肠道恶性肿瘤；化疗；大豆肽；二陈汤加味；营养状态；生活质量
|
Effects of Soybean Peptide Combined with Modified Erchen
Decoction on Nutritional Status and Quality of Life in Patients withMiddle-Advanced Gastrointestinal Malignant Tumors During
Chemotherapy
|
Derong Chen,Yan Liu,Meng Wang
Linyi Jinluo Hospital, Linyi Shandong 230036, China
|
Abstract：Objective To investigate the effects of soybean peptide combined with Modified Erchen Decoction on the nutritional status and quality of life in patients with middle-advanced gastrointestinal malignant tumors during
chemotherapy.Methods One hundred patients with middle-advanced gastrointestinal malignant tumors admitted to our hospital from January 2024 to May 2025 were randomly selected for the study and divided into two groups using a random
number table method. The control group (n=50) received conventional nutritional support. The observation group (n=50)
received a combination of soybean peptide and Modified Erchen Decoction. The efficacy of the two groups was compared.Results The incidence of chemotherapy-related adverse reactions in the observation group was lower than that in
the control group (P<0.05). The nutritional status and quality of life scores after intervention in the observation group were better than those in the control group(P<0.05).Conclusion For patients with middle-advanced gastrointestinal malignant
tumors during chemotherapy, the combination of soybean peptide and Modified Erchen Decoction can reduce
chemotherapy-related adverse reactions and also improve patients' nutritional status and quality of life, making it worthy of
promotion.
Keywords : Middle-advanced gastrointestinal malignant tumors; Chemotherapy; Soybean peptide; Modified Erchen Decoction;Nutritional status; Quality of life
参考文献
[1] 陈可欣,陈万青,黄育北,等.常见恶性肿瘤联合筛查专家共识(2025 版)[J].中国肿瘤,2025,34(8):583-610.
[2] 芮红霞,张冬婷,张晓雨,等.GLIM标准在胃肠道恶性肿瘤患者营养不良诊断中的应用研究[J]. 肿瘤代谢与营养电子杂志,2023,10(1):113-119.
[3] 吴苏宁,寇晓霞,仇金荣.老年恶性肿瘤病人的营养状况与支持治疗[J].实用老年医学,2020, 34(8):763-766,770.
[4] 张津铖,孙小梅,阳优战,等.以晚期胃肠恶性肿瘤为例论化疗方案的中医特性[J].环球中医药,2023,16(8):1596-1599.
[5] 代忠,陶丰娟,吉雪,等.二陈汤加味联合肠内营养支持对中晚期胃肠道恶性肿瘤患者化疗期间营养状态及生活质量的影响[J].河北中医,2021,43(10):1658-1661,1665.
[6] KwameWA.生物活性大豆肽对改善急性营养不良状况的营养特性研究[D].华南理工大学,2021.
[7] 中国抗癌协会肿瘤营养与支持治疗专业委员会肿瘤营养通路学组.中国恶性肿瘤营养治疗通路专家共识[M].人民卫生出版社:201803:71.
[8] 罗希,蔡斌,金薇薇.胃肠道恶性肿瘤患者的营养状 态研究[J].重庆 医学 ,2024,53(20):3065- 3071.
[9] 谭秋实,邵晶,周丽丽,等.大豆肽补充量和运动时间对大鼠血清游离氨基酸水平的影响[J].中国运动医学杂志,2022,41(4):288-299.
[10] 钟灼,高飞,赵永心,等.125I放射性粒子植入术后卡培他滨单药化疗联合二陈汤治疗晚期结直肠癌疗效分析[J].中国肿瘤临床与康复,2021, 28(3):257-262.
|
|
|
论文收录证明 / 文献检索报告
Document Retrieval Certificate / Proof of Publication Indexing
作者贡献声明 / 贡献确认书
Author Contribution Statement / Certificate of Authorship Contribution
同行评审报告 / 评审意见
Peer Review Report / Peer Review Comments
利益冲突
Conflict of Interest
作者声明不存在任何利益冲突。
The author declares no conflict of interest.
|
|
